Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice

Viral Immunology

Volumn 9, Issue 3, 1996, Pages 195-205

  Christian, Angela Y ^a,b   Barna, Maria ^a   Bi, Zhengbiao ^a,c   Reiss, Carol S ^a  

^a NEW YORK UNIVERSITY   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Aaron Diamond AIDS Research Centre   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE SYNTHASE; VIRUS ANTIGEN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; ENCEPHALITIS; ENZYME INDUCTION; HELPER CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MICROGLIA; MOUSE; NATURAL KILLER CELL; NONHUMAN; OLFACTORY BULB; SURVIVAL RATE; T LYMPHOCYTE; VESICULAR STOMATITIS VIRUS; VIRUS TITRATION;

ANIMALIA; VESICULAR STOMATITIS VIRUS;

EID: 0029806757     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1996.9.195     Document Type: Article

References (36)

1. Alwan, W.H., W.J. Kozlowska, and P.J.M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-90.
2. Barna, M., T. Komatsu, and C.S. Reiss 1996. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. J. Virol. 223 (2) Sept. 15, 1996, in press.
3. Bi, Z., M. Barna, T. Komatsu, and C.S. Reiss. 1995 Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity. J. Virol. 69:6466-6472.
4. Bi, Z., P. Quandt, M. Barna, and C.S. Reiss. 1995. IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system J. Immunol. 155:5684-5689.
5. Bi, Z., and C.S. Reiss 1995. Inhibition of vesicular stomatitis virus infection of the central nervous system. J. Virol. 69:2208-2213.
6. Bohme, G.A., C. Bon, J.M. Stutzman, A. Doble, and J.C. Blanchard. 1991. Possible involvement of nitric oxide in long-term potentiation. Eur. J. Pharmacol. 199:379-381.
7. Bredt, D.S., and S.H. Snyder 1994. Nitric oxide: a physiological messenger molecule. Annu. Rev. Biochem. 63:175-195.
8. Corradin, S.B., J. Mauel, S.D. Donini, E. Quattrocci, and P. Ricciardi-Castagnoli, 1993. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia 7:255-262.
9. Cserr, H.F., and P.M. Knopf 1992. Cervical lymphatics, the blood brain barrier, and the immunoreactivity of the brain: A new view. Immunol. Today 13:507-512.
10. Fabry, Z., C.S. Raine, and M.N. Hart 1994. Nervous tissue as an immune compartment: The dialect of the immune response in the CNS. Immunol. Today 15:218-212.
11. Farrar, M.A., and R.D. Schreiber 1993. The molecular biology of interferon-γ and its receptor. Ann. Rev. Immunol. 11:571-611.
12. d system. J. Virol. 65:4950-4958.
13. Galea, E., D.J. Reis, and D.C. Feinstein 1994. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:406-414.
14. Harris, N., R. Mark, L. Buller, and G. Karupiah 1995. Gamma-interferon-induced nitric oxide-mediated inhibition of vaccicia virus replication. J. Virol. 69:910-918.
15. Hertz, L., D.E. McFarlin, and B.H. Waksman 1990. Astrocytes:auxiliary cells for immune responses in the central nervous system? Immunol. Today 11:265-268.
16. Hsieh, C-S., S.E. Macatonia, A. O'Garra, and K.M. Murphy. 1995. T cell genetic background determines default T helper phenotype development in vitro. J. Exp. Med. 181:713-721.
17. Huang, A.S., and E.K. Manders 1972. RNA synthesis in vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering virus particles. J. Virol. 9:909-920.
18. Huneycutt, B.S., Z. Bi, C.J. Aoki, and C.S. Reiss 1993. Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice. J. Virol. 67:4980-4987.
19. Huneycutt, B.S., I.V. Plakhov, Z. Shusterman, S.M. Bartido, A.S. Huang, C.S. Reiss, and C. Aoki, 1994. Distribution of vesicular stomatitis virus proteins in the brain of BALB/c mice following intranasal inoculation: an immunohistochemical study. Brain Res. 635:81-95.
20. Karupiah, G., Q. Xie, R.L.M. Buller, C. Nathan, C. Duarte, and J.D. Macmicking, 1993. Inhibition of viral replication by interferon-γ induced nitric oxide synthase. Science 261:1445-1448.
21. 19a. Komatsu, T., Z. Bi, and C.S. Reiss 1996. IFN-γ-induced type I nitric oxide synthase activity inhibits viral replication in neurons. J. Nueroimmunol., in press.
22. Kundig, T.M., H. Hengartner, and R.M. Zinkernagel 1993. T cell-dependent IFN-γ exerts an antiviral effect in the central nervous system, but not in peripheral solid organs. J. Immunol. 150:2316-2323.
23. Lee, S.C., D.M. Dickson, C.F. Brosnan, and A. Casadevell 1994. Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism. J. Exp. Med. 180:365-374.
24. Lotan, M., and M. Schwartz 1994. Cross-talk between the immune system and the nervous system in response to injury: Implications for regeneration. FASEB J. 8:1026-1030.
25. Lundh, B., K. Kristensson, and E. Norrby. 1987. Selective infection of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses. Neuropathol. Appl. Neurobiol. 13:111-122.
26. Mucke, L., and M. Eddleston 1993. Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J. 7:1226-1232.
27. Nathan, C., and Q.W. Xie, 1994. Nitric oxide synthase:roles, tolls, and controls. Cell 78:915-918.
28. Openshaw, P.J.M., E.E. Murphy, N.A. Hoskin, V. Maino, K. Davis, K. Murphy, and A. O'Gara. 1996. Heterogeneity of intracellular cytokine synthesis at single cell level in polarized T helper 1 and T helper-2 populations. J. Exp. Med. 182:1357-1368.
29. Palmer, R.M., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxation factor. Nature (London) 327:524-526.
30. Plakhov, I.V., C. Aoki, E.E. Arlund, and C.S Reiss 1995. The earliest events in VSV infection of the murine olfactory neuroepithelium and entry of the central nervous system. Virology 209:257-262.
31. Reiner, S.L., and R.M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177.
32. Seguin, M.C., F.M., Klotz, I. Schneider, J.P. Weir, M. Goodbary, M. Slayter, J.J. Raney, J.U. Aniagolu, and S.J. Green 1994. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitos, involvement of interferon-gamma and CD8+ T cells. J. Exp. Med. 180:353-364.
33. Snyder, S.H. 1992. Nitric oxide: First in a new class of neurotransmitters? Science 257:494-496.
34. Stenger, S., H. Thuring, M. Rollinghoff, and C. Bogdan 1994. Tissue expression of inducible nitric oxide synthase is closely associated with resistance to malaria. J. Exp. Med. 180:783-795.
35. Wagner, R.R., 1987. In R.R. Wagner (ed.): The rhabdovirus. Plenum Press, New York.
36. Zinkernagel, R.M. 1993. In Fundamental immunology, 3rd ed. Raven Press, New York.